Eicosapentaenoic acid potentiates the therapeutic effects of adipose tissue-derived mesenchymal stromal cells on lung and distal organ injury in experimental sepsis

[1] Gotts JE(2016)Sepsis: pathophysiology and clinical management BMJ. 353 i1585-588

[2] Matthay MA(2015)Pharmacological treatments for acute respiratory distress syndrome: systematic review Minerva Anestesiol 81 567-1286

[3] Duggal A(2014)Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema Respir Res 15 118-e140

[4] Ganapathy A(2017)Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicles mitochondrial transfer Am J Respir Crit Care Med 196 1275-312

[5] Ratnapalan M(2018)Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome Crit Care Med 46 e132-L1013

[6] Adhikari NK(2019)Serum from asthmatic mice potentiates the therapeutic effects of mesenchymal stromal cells in experimental allergic asthma Stem Cells Transl Med 8 301-32

[7] Antunes MA(2012)Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes Am J Physiol Lung Cell Mol Physiol. 302 L1003-1057

[8] Abreu SC(2015)Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis Stem Cell Res Ther 6 199-635

[9] Cruz F(2014)Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury J Pineal Res 57 16-32

[10] Teixeira AC(2016)Treatment with human Wharton’s jelly-derived mesenchymal stem cells attenuated sepsis-induced kidney injury, liver, injury and endothelial dysfunction Stem Cell Trans Med 5 1048-162

[1] Gotts JE(2016)Sepsis: pathophysiology and clinical management BMJ. 353 i1585-588

[2] Matthay MA(2015)Pharmacological treatments for acute respiratory distress syndrome: systematic review Minerva Anestesiol 81 567-1286

[3] Duggal A(2014)Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema Respir Res 15 118-e140

[4] Ganapathy A(2017)Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicles mitochondrial transfer Am J Respir Crit Care Med 196 1275-312

[5] Ratnapalan M(2018)Mesenchymal stem cells from bone marrow, adipose tissue, and lung tissue differentially mitigate lung and distal organ damage in experimental acute respiratory distress syndrome Crit Care Med 46 e132-L1013

[6] Adhikari NK(2019)Serum from asthmatic mice potentiates the therapeutic effects of mesenchymal stromal cells in experimental allergic asthma Stem Cells Transl Med 8 301-32

[7] Antunes MA(2012)Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes Am J Physiol Lung Cell Mol Physiol. 302 L1003-1057

[8] Abreu SC(2015)Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis Stem Cell Res Ther 6 199-635

[9] Cruz F(2014)Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury J Pineal Res 57 16-32

[10] Teixeira AC(2016)Treatment with human Wharton’s jelly-derived mesenchymal stem cells attenuated sepsis-induced kidney injury, liver, injury and endothelial dysfunction Stem Cell Trans Med 5 1048-162